142 related articles for article (PubMed ID: 12084857)
1. Pharmacokinetics of vincristine monotherapy in childhood acute lymphoblastic leukemia.
Groninger E; Meeuwsen-de Boar T; Koopmans P; Uges D; Sluiter W; Veerman A; Kamps W; de Graaf S
Pediatr Res; 2002 Jul; 52(1):113-8. PubMed ID: 12084857
[TBL] [Abstract][Full Text] [Related]
2. Vincristine pharmacokinetics and response to vincristine monotherapy in an up-front window study of the Dutch Childhood Leukaemia Study Group (DCLSG).
Groninger E; Meeuwsen-de Boer T; Koopmans P; Uges D; Sluiter W; Veerman A; Kamps W; de Graaf S
Eur J Cancer; 2005 Jan; 41(1):98-103. PubMed ID: 15617994
[TBL] [Abstract][Full Text] [Related]
3. Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents.
Frost BM; Lönnerholm G; Koopmans P; Abrahamsson J; Behrendtz M; Castor A; Forestier E; Uges DR; de Graaf SS
Acta Paediatr; 2003 May; 92(5):551-7. PubMed ID: 12839283
[TBL] [Abstract][Full Text] [Related]
4. Vincristine pharmacokinetics after repetitive dosing in children.
Gidding CE; Meeuwsen-de Boer GJ; Koopmans P; Uges DR; Kamps WA; de Graaf SS
Cancer Chemother Pharmacol; 1999; 44(3):203-9. PubMed ID: 10453721
[TBL] [Abstract][Full Text] [Related]
5. Vincristine pharmacokinetics is related to clinical outcome in children with standard risk acute lymphoblastic leukemia.
Lönnerholm G; Frost BM; Abrahamsson J; Behrendtz M; Castor A; Forestier E; Heyman M; Uges DR; de Graaf SS
Br J Haematol; 2008 Aug; 142(4):616-21. PubMed ID: 18537965
[TBL] [Abstract][Full Text] [Related]
6. Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia.
Plasschaert SL; Groninger E; Boezen M; Kema I; de Vries EG; Uges D; Veerman AJ; Kamps WA; Vellenga E; de Graaf SS; de Bont ES
Clin Pharmacol Ther; 2004 Sep; 76(3):220-9. PubMed ID: 15371983
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia.
Kearns CM; Blakley RL; Santana VM; Crom WR
Cancer Res; 1994 Mar; 54(5):1235-9. PubMed ID: 7906999
[TBL] [Abstract][Full Text] [Related]
8. Vincristine pharmacokinetics in children with Down syndrome.
Lönnerholm G; Frost BM; Söderhäll S; de Graaf SS
Pediatr Blood Cancer; 2009 Jan; 52(1):123-5. PubMed ID: 18615507
[TBL] [Abstract][Full Text] [Related]
9. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
Den Boer ML; Harms DO; Pieters R; Kazemier KM; Gobel U; Körholz D; Graubner U; Haas RJ; Jorch N; Spaar HJ; Kaspers GJ; Kamps WA; Van der Does-Van den Berg A; Van Wering ER; Veerman AJ; Janka-Schaub GE
J Clin Oncol; 2003 Sep; 21(17):3262-8. PubMed ID: 12947061
[TBL] [Abstract][Full Text] [Related]
10. Vincristine pharmacodynamics and pharmacogenetics in children with cancer: a limited-sampling, population modelling approach.
Moore AS; Norris R; Price G; Nguyen T; Ni M; George R; van Breda K; Duley J; Charles B; Pinkerton R
J Paediatr Child Health; 2011 Dec; 47(12):875-82. PubMed ID: 21658147
[TBL] [Abstract][Full Text] [Related]
11. Etoposide pharmacokinetics in children treated for acute myeloid leukemia.
Palle J; Frost BM; Gustafsson G; Hellebostad M; Kanerva J; Liliemark E; Schmiegelow K; Lönnerholm G;
Anticancer Drugs; 2006 Oct; 17(9):1087-94. PubMed ID: 17001183
[TBL] [Abstract][Full Text] [Related]
12. Vincristine disposition in children with acute lymphoblastic leukemia.
de Graaf SS; Bloemhof H; Vendrig DE; Uges DR
Med Pediatr Oncol; 1995 Apr; 24(4):235-40. PubMed ID: 7700168
[TBL] [Abstract][Full Text] [Related]
13. Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia.
Yang L; Panetta JC; Cai X; Yang W; Pei D; Cheng C; Kornegay N; Pui CH; Relling MV
J Clin Oncol; 2008 Apr; 26(12):1932-9. PubMed ID: 18421047
[TBL] [Abstract][Full Text] [Related]
14. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: multi-institutional collaborative study.
Frost BM; Eksborg S; Björk O; Abrahamsson J; Behrendtz M; Castor A; Forestier E; Lönnerholm G
Med Pediatr Oncol; 2002 May; 38(5):329-37. PubMed ID: 11979457
[TBL] [Abstract][Full Text] [Related]
16. Vincristine-induced apoptosis in vivo in peripheral blood mononuclear cells of children with acute lymphoblastic leukaemia (ALL).
Groninger E; de Graaf SS; Meeuwsen-de Boer GJ; Sluiter WJ; Poppema S
Br J Haematol; 2000 Dec; 111(3):875-8. PubMed ID: 11122150
[TBL] [Abstract][Full Text] [Related]
17. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
Harnicar S; Adel N; Jurcic J
J Oncol Pharm Pract; 2009 Sep; 15(3):175-82. PubMed ID: 19282418
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
[TBL] [Abstract][Full Text] [Related]
19. Malnourished Malawian patients presenting with large Wilms tumours have a decreased vincristine clearance rate.
Israels T; Damen CW; Cole M; van Geloven N; Boddy AV; Caron HN; Beijnen JH; Molyneux EM; Veal GJ
Eur J Cancer; 2010 Jul; 46(10):1841-7. PubMed ID: 20382523
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with acute lymphoblastic leukemia in first relapse.
Hijiya N; Stewart CF; Zhou Y; Campana D; Coustan-Smith E; Rivera GK; Relling MV; Pui CH; Gajjar A
Cancer; 2008 May; 112(9):1983-91. PubMed ID: 18318429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
